| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Dec 5, 2025 | SELLAS Life Sciences Group, Inc. | SVP, Chief Development Officer | Sell | 42.5 | -63,800 | -19.84% | ✗ | $95.7K |
| Dec 4, 2024 | Dec 5, 2024 | SELLAS Life Sciences Group, Inc. | SVP, Chief Development Officer | Sell | 47.5 | -8,256 | -6.68% | ✗ | $9.3K |
| May 7, 2015 | May 22, 2015 | Actinium Pharmaceuticals, Inc. | COO | Sell | 27.5 | -2,940 | -72.41% | ✗ | $7.4K |